Health  Vol.7 No.10 , October 2015
Selective Association between Cephalosporin, Quinolone, Macrolide, and Penicillin Antibiotic Consumption and Childhood Obesity in Europe
ABSTRACT
The accelerated weight gain in productive animals as a result of feeding antibiotic enriched fodder has been well known for decades. The better energy harvest is the result of modified gut microbiota as a consequence of applied antibiotics. Similar mechanisms might result obesity in humans as well. Objectives: Finding associations between global antibiotic consumption of different classes in EU countries and obesity data in adults and children prove that antibiotics might play a significant role in the development of obesity “epidemics” and related illnesses. Methods: Antibiotic consumption data were compared with obesity figures in adults and children in European countries and statistically analyzed for significance. Results: Significant correlation was found between the average yearly consumption of cephalosporins (p = 0.007), quinolones (p = 0.031), macrolides (p = 0.000083) and childhood obesity data, but no significant association was observed with the average penicillin consumption. No association was observed between adult obesity and any of the antibiotic classes studied. Conclusions: Our results support the hypothesis that different types of antibiotics might influence the development of obesity among children, and this finding can serve as a unified explanation for the development of obesity “epidemics”, similarly to the obesity and gut flora alteration-related diseases (type 2 diabetes mellitus, autism, etc.).

Cite this paper
Ternak, G. , Edel, Z. , Feiszt, Z. , Szekeres, J. , Visegrady, B. and Wittmann, I. (2015) Selective Association between Cephalosporin, Quinolone, Macrolide, and Penicillin Antibiotic Consumption and Childhood Obesity in Europe. Health, 7, 1306-1314. doi: 10.4236/health.2015.710145.
References
[1]   Butaye, P., Devriese, L.A. and Haesebrouck, F. (2003) Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria. Clinical Microbiology Reviews, 16, 175-188.
http://dx.doi.org/10.1128/CMR.16.2.175-188.2003

[2]   Robinson, C.J. and Young, V.B. (2010) Antibiotic Administration Alters the Community Structure of the Gastrointestinal Micobiota. Gut Microbes, 1, 279-284.
http://dx.doi.org/10.4161/gmic.1.4.12614

[3]   Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes, 56, 1761-1772.
http://dx.doi.org/10.2337/db06-1491

[4]   Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. (2008) Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice. Diabetes, 57, 1470-1481.
http://dx.doi.org/10.2337/db07-1403

[5]   Mansi, Y., Abdelaziz, N., Ezzeldin, Z. and Ibrahim, R. (2011) Randomized Controlled Trial of a High Dose of Oral Erythromycin for the Treatment of Feeding Intolerance in Preterm Infants. Neonatology, 100, 290-294.
http://dx.doi.org/10.1159/000327536

[6]   Ternak, G. (2005) Antibiotics May Act As Growth/Obesity Promoters in Humans as an Inadvertent Result of Antibiotic Pollution? Medical Hypotheses, 64, 14-16.
http://dx.doi.org/10.1016/j.mehy.2004.08.003

[7]   Gough E.K., Moodie, Erica, E.M., Prendergast, A.J., Johnson, S.M.A., Humphrey, J.H, Stoltzfus, R.J., et al. (2014) The Impact of Antibiotics on Growth in Children in Low and Middle Income Countries: Systematic Review and Meta-Analysis of Randomised Controlled Trials. British Medical Journal, 348, g2267.
http://dx.doi.org/10.1136/bmj.g2267

[8]   Cho, I., Yamanishi, S., Cox, L., Methé, B.A., Zavadil, J., Li, K., et al. (2012) Antibiotics in Early Life Alter Murine Colonic Microbiome and Adiposity. Nature, 488, 621-626.
http://dx.doi.org/10.1038/nature11400

[9]   Ajslev, T.A., Andersen, C.S., Gamborg, M., Sorensen, T.I. and Jess, T. (2011) Childhood Overweight after Establishment of the Gut Microbiota: The Role of Delivery Mode, Pre-Pregnancy Weight and Early Administration of Antibiotics. International Journal of Obesity (London), 35, 522-29.
http://dx.doi.org/10.1038/ijo.2011.27

[10]   Ray, K. (2012) Gut Microbiota: Adding Weight to the Microbiota’s Role in Obesity-Exposure to Antibiotics Early in Life Can Lead to Increased Adiposity. Nature Reviews Gastroenterology & Hepatology, 11, 615.
http://dx.doi.org/10.1038/nrgastro.2012.175

[11]   Trasande, L., Blustein, J., Liu, M., Corwin, E., Cox, L.M. and Blaser, M.J. (2013) Infant Antibiotic Exposures and Early-Life Body Mass. International Journal of Obesity (London), 37, 16-23.
http://dx.doi.org/10.1038/ijo.2012.132

[12]   Goossens, H., Ferech, M., Vander Stichele, R. and Elseviers, M. (2005) ESAC Project Group. Outpatient Antibiotic Use in Europe and Association with Resistance: A Cross-National Database Study. Lancet, 365, 579-587.
http://dx.doi.org/10.1016/S0140-6736(05)70799-6

[13]   Versporten, A., Coenen, S., Adriaenssens, N., Muller, A., Minalu, G., Faes, C., et al., and On Behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): Outpatient Cephalosporin Use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy, 66, vi25-vi35.
http://dx.doi.org/10.1093/jac/dkr455

[14]   Adriaenssens, N., Coene, S., Versporten, A., Muller, A., Minalu, G., Faes, C., et al., and on Behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): Outpatient Macrolide, Lincosamide and Streptogramin (MLS) Use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy, 66, vi37-vi45.
http://dx.doi.org/10.1093/jac/dkr456

[15]   Adriaenssens, N., Coene, S., Versporten, A., Muller, A., Minalu, G., Faes, C., et al., and on Behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): Outpatient Quinolone Use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy, 66, vi47-vi56.
http://dx.doi.org/10.1093/jac/dkr457

[16]   Versporten, A., Coenen, S., Adriaenssens, N., Muller, A., Minalu, G., Faes, C., et al., and on Behalf of the ESAC Project Group (2011) European Surveillance of Antimicrobial Consumption (ESAC): Outpatient Penicillin Use in Europe (1997-2009). Journal of Antimicrobial Chemotherapy, 66, vi13-vi23.
http://dx.doi.org/10.1093/jac/dkr454

[17]   OECD/European Union (2010) Overweight and Obesity among Children. In Health at a Glance: Europe 2010, OECD Publishing.

[18]   Health at a Glance 2011 OECD Indicators, Overweight and Obesity among Children.

[19]   OECD (2012) Overweight and Obesity among Adults. In Health at a Glance: Europe 2012, OECD Publishing.

[20]   OECD (2013) Health at a Glance 2013: OECD Indicators, OECD Publishing.
http://dx.doi.org/10.1787/health_glance-2013-en

[21]   WHO Report: Report on Modelling Adulthood Obesity across the WHO European Region, Prepared by Consultants (Led by T. Marsh and Colleagues) for the WHO Regional Office for Europe in 2013. http://www.euro.who.int/

[22]   Breda, J. (2014) WHO. Childhood Obesity Surveillance Initiative
http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/activities/monitoring-and-surveillance/who-european-childhood-obesity-surveillance-initiative-cosi

[23]   Savvaa, S.C., Kouridesa, Y.A., Hadjigeorgioua, C. and Tornaritis, M.J. (2014) Overweight and Obesity Prevalence and Trends in Children and Adolescents in Cyprus 2000-2010. Obesity Research & Clinical Practice, 8, e426-e434.

[24]   Kootte, R.S., Vrieze, A., Holleman, F., Dallinga-Thie, G.M., Zoetendal, E.G., de Vos, W.M., et al. (2012) The Therapeutic Potential of Manipulating Gut Microbiota in Obesity and Type 2 Diabetes Mellitus. Diabetes, Obesity and Metabolism, 14, 112-120.
http://dx.doi.org/10.1111/j.1463-1326.2011.01483.x

[25]   Angelakis, E., Merhej, V. and Raoult, D. (2013) Related Actions of Probiotics and Antibiotics on Gut Microbiota and Weight Modification. The Lancet Infectious Diseases, 13, 889-899.
http://dx.doi.org/10.1016/S1473-3099(13)70179-8

[26]   Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., LaBaer, J., Adams, J.B. and Krajmalnik-Brown, R. (2013) Reduced Ncidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children. PLoS One, 8, e68322.
http://dx.doi.org/10.1371/journal.pone.0068322

[27]   Finegold, S.M., Downes, J. and Summanen, P.H. (2012) Microbiology of Regressive Autism. Anaerobe, 18, 260-262.
http://dx.doi.org/10.1016/j.anaerobe.2011.12.018

[28]   Borody, T., Leis, S., Campbell, J., Torres, M. and Nowak, A. (2011) Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis (MS). The American Journal of Gastroenterology, 106, S352.

[29]   Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., et al. (2012) Transfer of Intestinal Microbiota from Lean Donors Increases Insulin Sensitivity in Individuals with Metabolic Syndrome. Gastroenterology, 143, 913-916.
http://dx.doi.org/10.1053/j.gastro.2012.06.031

[30]   Jernberg, C., Lofmark, S., Edlund, C. and Jansson, J.K. (2007) Long-Term Ecological Impacts of Antibiotic Administration on the Human Intestinal Microbiota. The ISME Journal, 1, 56-66.
http://dx.doi.org/10.1038/ismej.2007.3

 
 
Top